Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 11401 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Terns Pharmaceuticals Inc.

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  AxoGen, Inc.

MacroGenics to Participate in Upcoming Investor Conference

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  MacroGenics, Inc.

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Tempest Therapeutics Inc.

Monthly information on share capital and company voting rights

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Cellectis Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Oric Pharmaceuticals Inc.

Ascend to showcase health care innovations at MD&M West

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

FDA Roundup: February 2, 2024

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  U.S. Food and Drug Administration

Akel Homes Demonstrates Enthusiastic Support as Silver Benefactor for the 2024 LLS Black Tie Gala, Eager to Contribute to Life-Saving Cancer Research

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Insmed Incorporated

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Akebia Therapeutics, Inc.

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Syndax Pharmaceuticals, Inc.

Proven Behavior Solutions Appoints Mark Donovan to Board of Directors

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

CALIFORNIA SURGEON GENERAL VISITS SONOMA COUNTY TO PROMOTE TRAUMA INFORMED SCHOOLS

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

Spyre Therapeutics Announces Grants of Inducement Awards

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Spyre Therapeutics, Inc.

Global Medical Marijuana Market Report 2024: Market Value to Reach $154.83 Billion by 2034 from $16.88 Billion in 2023

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

Merck & Co Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

JMIR MEDICAL INFORMATICS INVITES SUBMISSIONS ON AI LANGUAGE MODELS IN HEALTH CARE

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Valeo Pharma Inc.

Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Regeneron Pharmaceuticals Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑